Therapeutic Drug Monitoring in tuberculosis patients. Setup and optimisation of therapeutic drug monitoring at the Research Center Borstel
Recruiting
- Conditions
- A15.9Respiratory tuberculosis unspecified, confirmed bacteriologically and histologically
- Registration Number
- DRKS00009869
- Lead Sponsor
- Medizinische Klinik des Foschungszentrums Borstel
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
pan-susceptible, MDR and XDR Tuberculosis
Exclusion Criteria
Currently pregnant or breastfeeding, participation/enrollement not feasible according to a physician, unable to provide informed consent, no consent obtained
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To establish the HPLC-MS-MS-based method for measuring drug concentrations and identify the optimal sampling strategy.
- Secondary Outcome Measures
Name Time Method